Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warning Letters Increasingly Targeting Internet Claims

This article was originally published in The Tan Sheet

Executive Summary

More than 80% of the warning letters concerning OTC drug and dietary supplement products sent in the last few months have focused on Internet claims
Advertisement

Related Content

Noni warning letter
Noni warning letter
Noni warning letter
Nature’s Youth Supplement Relabeled Without Growth Factor Reference
Nature’s Youth Supplement Relabeled Without Growth Factor Reference
Niacin Supplement For High Cholesterol Targeted In Warning Letter
HHS/FDA Ephedra Strategy: A Risk Management Approach?
Nicotine Lollipops Active Ingredient Nicotine Salicylate “Illegal” – FDA
“Misbranded” Rosacea, Acne Treatments Targeted In FDA Warning Letters
“Misbranded” Rosacea, Acne Treatments Targeted In FDA Warning Letters

Topics

Advertisement
UsernamePublicRestriction

Register

PS094269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel